Genetic testing and precision medicine company.
FDA draft guidance to regulate laboratory developed tests and companion diagnostics.
Legislation to further regulate clinical labs under CLIA and/or FDA (legislation not yet introduced). Implementation of PL 113-93 (H.R. 4302): Protecting Access to Medicare Act of 2014.
Implementation of changes to Medicare payment for clinical laboratory tests.
FDA regulation of laboratory developed tests.
Medicare treatment of outpatient reimbursement for laboratory tests.
MED - Medical/Disease Research/Clinical Labs MMM - Medicare/Medicaid
136 - Centers For Medicare and Medicaid Services (CMS) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 136 - Centers For Medicare and Medicaid Services (CMS) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
TODD STRATEGY GROUP
1201 New York Avenue, NW, 8th Floor, Washington, DC, 20005, US
DANIEL M TODD PAUL EDATTEL DANIEL M TODD (Senior Health Counsel, Senate Finance Committee; Special Assistant, Office of Admin. Ct. - Medicare & Medicaid) PAUL EDATTEL (Chief Health Counsel, House Energy & Commerce Committee; Policy Assistant, Office of the Speaker; Professional Staff Member for the Majority at the House Energy & Commerce Committee; Legislative Assistant & Legislative Director, Rep. John Shadegg)
Senior Health Counsel, Senate Finance Committee; Special Assistant, Office of Admin. Ct. - Medicare & Medicaid Chief Health Counsel, House Energy & Commerce Committee; Policy Assistant, Office of the Speaker; Professional Staff Member for the Majority at the House Energy & Commerce Committee; Legislative Assistant & Legislative Director, Rep. John Shadegg